RudaCure ha sido seleccionada para Incheon City's I+D Activation Project 'I+D Planning Consulting Support Project' for consulting on RCI002 (tratamiento del dolor).
A través de esto selección, la empresa recibirá consulting apoyo for the comercialización and IP protection of tratamiento del dolor RCI002 — currently in preparation for PCT and U.S. solicitud de patentes — as well as IP portfolio construction. This will serve as the basis for establishing its I+D strategy.